Endothelial Dysfunction in Patients with Rheumatoid Arthritis: the Role of Hypertension

Area of Science:

• Cardiovascular Medicine
• Rheumatology
• Immunology

Background:

• Rheumatoid arthritis (RA) is a common autoimmune disorder linked to chronic systemic inflammation.
• Patients with RA have a significantly increased risk of cardiovascular mortality, which is the leading cause of death.
• Hypertension is more prevalent in RA patients and exacerbates cardiovascular complications.

Purpose of the Study:

• To review the role of endothelial dysfunction in rheumatoid arthritis (RA).
• To examine the impact of hypertension as a mediator of cardiovascular disease in RA patients.
• To explore the interplay between inflammation, hypertension, and endothelial dysfunction in RA.

Main Methods:

• Review of existing data on endothelial dysfunction and hypertension in RA.
• Analysis of studies utilizing traditional and novel methods for evaluating endothelial dysfunction.
• Assessment of the relationship between endothelial dysfunction, hypertension, and inflammation in RA patients.

Main Results:

• Endothelial dysfunction is a key factor in the pathogenesis of hypertension and cardiovascular diseases in RA.
• Hypertension and chronic inflammation act synergistically to increase cardiovascular morbidity in RA patients.
• The presence and extent of endothelial dysfunction in RA, independent of hypertension, requires further investigation.

Conclusions:

• Hypertension, endothelial dysfunction, and systemic inflammation form a detrimental triad that elevates cardiovascular risk in RA.
• Early detection of endothelial dysfunction in RA is crucial for developing targeted therapies.
• Further research is needed to understand and mitigate cardiovascular complications in rheumatoid arthritis.